Shire raises full-year earnings forecast
Health / Medicine Related News
The speciality pharmaceutical maker boosts full-year earnings guidance as it shrugs off declining sales of a former blockbusting drug and takes advantage of its rival's problems
Source: FT.com - Pharmaceuticals